Julie Gerberding, MD, MPH

Dr. Julie Louise Gerberding is the President and CEO of the Foundation for the National Institutes of Health (FNIH), a non-profit organization that builds public-private-patient biomedical research partnerships to address important medical challenges in support of the NIH mission. She also co-chairs the CSIS Bipartisan Alliance for Global Health Security. Dr. Gerberding formerly served as President of Merck Vaccines and as Executive Vice President and Chief Patient Officer at Merck & Co., Inc.  From 2003-2009, Dr. Gerberding led the U.S. Centers for Disease Control and Prevention (CDC).  Her current board service includes HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University.  Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.

Back to Board of Directors and Officers